Drug Report History #128404
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-EN | Version v5-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-12-02 | 2020-12-02 |
| Drug Identification Number | 02237810 | 02237810 |
| Brand name | ANTITHROMBIN III NF | ANTITHROMBIN III NF |
| Common or Proper name | Antithrombin III (human) | Antithrombin III (human) |
| Company Name | SHIRE PHARMA CANADA ULC | SHIRE PHARMA CANADA ULC |
| Ingredients | ANTITHROMBIN III | ANTITHROMBIN III |
| Strength(s) | 1100UNIT | 1100UNIT |
| Dosage form(s) | KIT POWDER FOR SOLUTION | KIT POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20 mL | 20 mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2020-11-13 | 2020-11-13 |
| Actual start date | 2020-11-13 | 2020-11-13 |
| Estimated end date | 2020-12-15 | 2020-12-15 |
| Actual end date | 2020-12-01 | 2020-12-01 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Resolved | Resolved |
| Health Canada comments |